Research News – Monday, May 6, 2024
Published: Monday, May 6, 2024
Workshops and Seminars
The Institutional Research Core Facility is hosting a Lunch and Learn Illumina seminar introducing the new XLEAP chemistry for our NextSeq2000 sequencer that will allow us to reduce costs. Please see attachment for additional information.
When: Thursday, May 16th
Where: BRC 109
When: 12:00 PM – 1:30 PM
Lunch will be provided for those who register.
At this event, NIH staff will provide a general overview of the grants process and will walk through essential aspects of applying for funding. They will also offer information for finding the right fit for your research and discuss peer review, NIH and applicant institution roles and responsibilities, and resources to help along the way.
This webinar will include a substantial period for Q&A, featuring a panel of NIH experts answering questions submitted during registration, as well as additional queries raised during the live discussion.
NIH Health Sciences Innovation and Entrepreneurship (HSE) Seminar Series
Funding for Early- Career Scientists to Commercialize Cancer Technologies
Online Friday, May 10, 2024, 12PM-1PM-CT
See attached flyer for additional information
An Introduction to HELIOS Open Scholarship
Tuesday, May 7, 2024, 10 a.m. – 11:30 a.m. CT
Please join us to learn more about the Higher Education Leadership Initiative for Open Scholarship (
HELIOS Open) and its importance to research at OU from a panel of experts working in this area. HELIOS Open seeks to promote a more transparent, inclusive, and trustworthy research ecosystem. Panelists include Danny Anderson, President Emeritus of Trinity University, Geeta Swamy, HELIOS Open Strategic Lead & Duke University Associate Vice President for Research & Vice Dean for Science Integrity, and Caitlin Carter, HELIOS Open Program Manager. There will be time for Q & A with the panelists following the presentation. This program is hosted by the OU HELIOS Advisory Council.
Event Venue/Location: Zoom link will be provided after registration.
OUHSC Funding Opportunities
The
Pew Biomedical Scholars program provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program awards grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the Assistant Professor level. The 2025 award will be in the amount of $300,000 ($75,000 per year for four years). Eligible faculty are invited to submit an internal pre-proposal via email to
HSCORA@ouhsc.edu by 5 pm on May 6, 2024. Details can be found in the attached announcement
Oklahoma Biotech Startup Programs Concept Program
OKBioStart Program is a grant-funded, multi-institutional program for innovators, founders, and the life science community in the greater Oklahoma City ten-county region that accelerates the translation of innovative concepts into commercially viable life sciences (Biotech, MedTech, or Virtual Health) technologies. See program announcement attached for specific deadline dates associated with each program.
Office of Technology Commercialization presents the following opportunity for
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click
here for more information, or email
otc@ou.edu or
gina-mcmillen@ouhsc.edu).
An American pharmaceutical company focused on rare diseases seeks novel therapeutics with defined target, mechanism of action and proven efficacy for non-malignant hematological diseases. Modalities of interest include small molecule, RNA-based, proteins/peptides and antibodies. Therapeutics that act on SPHK1, HRI, BCL11A and ALAS2 are of particular interest. Out of scope: cell and gene therapies, repurposed or reformulated drugs, and treatments that act on LRF/SBTB7A, EED complex, LSD1, HIF-PHIs and TcRNs. Submission entails a one-page 200-300 word non-confidential brief. Deadline May 20th.
LifeArc, a non-profit medical research organization, is seeking innovative proposals to boost drug repurposing in motor neuron disease. Approaches of interest include preclinical stage research with a repurposed drug or drug combination. Submission of an Expression of Interest form is required as part of the application process; more information can be found at the
LifeArc – Drug Repurposing in MND.
Deadline May 10th.
(NOT-NS-24-080)
(NOT-MH-24-260)
(NOT-MH-24-261)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
Application Deadline: October 17, 2024
OTHER Funding Opportunities
Vilcek Foundation
2025 Vilcek Prizes for Creative Promise in Biomedical Science
Deadline June 10, 2024